CN111855997A - Novel immunohistochemical three-in-one reagent formula - Google Patents

Novel immunohistochemical three-in-one reagent formula Download PDF

Info

Publication number
CN111855997A
CN111855997A CN202010769508.3A CN202010769508A CN111855997A CN 111855997 A CN111855997 A CN 111855997A CN 202010769508 A CN202010769508 A CN 202010769508A CN 111855997 A CN111855997 A CN 111855997A
Authority
CN
China
Prior art keywords
immunohistochemical
triton
bsa
tween
pbs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010769508.3A
Other languages
Chinese (zh)
Inventor
雍学安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Lituo Biotechnology Co ltd
Lituo Biotechnology Co ltd
Original Assignee
Hunan Lituo Biotechnology Co ltd
Lituo Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Lituo Biotechnology Co ltd, Lituo Biotechnology Co ltd filed Critical Hunan Lituo Biotechnology Co ltd
Priority to CN202010769508.3A priority Critical patent/CN111855997A/en
Publication of CN111855997A publication Critical patent/CN111855997A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to a novel immunohistochemical three-in-one reagent formula, belonging to the field of immunohistochemistry; the composite material consists of the following raw materials in mass number: 0.1-0.4g Triton X-100; 1ml-4ml hydrogen peroxide; 0.5ml-2ml goat serum; 0.1g-0.4g BSA; 0.01g to 0.04g of tween-20; 0.001g-0.01g EDTA; 0.1g-0.4g PC300 was dissolved in 17ml PBS, pH 7.4. The invention effectively shortens the immunohistochemical time and does not influence the immunohistochemical experiment effect.

Description

Novel immunohistochemical three-in-one reagent formula
Technical Field
The invention belongs to the field of immunohistochemistry, and particularly relates to a novel immunohistochemical three-in-one reagent formula.
Background
Immunohistochemistry is a method of determining the antigens (polypeptides and proteins) in tissue cells by applying the basic immunological principle, namely the principle of antigen-antibody reaction, namely the specific combination of antigens and antibodies, and developing color development agents (fluorescein, enzyme, metal ions and isotopes) of labeled antibodies through chemical reaction, and performing positioning, qualitative and relatively quantitative researches on the antigens, which is called immunohistochemistry (immunohistochemistry) or immunocytochemistry (immunocytochemistry).
Immunohistochemistry makes use of this principle. Firstly, a certain chemical substance in the tissue or cell is extracted and used as an antigen or a hapten, a specific antibody is obtained after the animal is immunized, and then the antibody is used for detecting the same kind of antigen substance in the tissue or cell. Since the complex of antigen and antibody is colorless, the site of antigen-antibody binding must also be visualized by histochemical methods to allow qualitative, localized or quantitative investigation of unknown antigens in tissues or cells.
In recent years, with the development of immunohistochemical techniques and the emergence of various specific antibodies, many difficult tumors have been clearly diagnosed. In routine pathological diagnosis of tumors, definitive morphological diagnosis is difficult to make in 5% -10% of cases by h.e. staining alone. In particular, the practical value of immunohistochemistry in tumor diagnosis and differential diagnosis is generally accepted, and the accuracy rate can reach 50 to 75 percent when the immunohistochemistry is used for differential diagnosis of low-differentiation or undifferentiated tumors.
Immunohistochemical experiments therefore represent a very large proportion of the in vitro diagnostic market. Carrying out conventional steps of immunohistochemical experiments, and preparing samples; antigen retrieval; permeating; eliminating endogenous peroxidase; sealing; primary antibody incubation; incubating and developing by using a secondary antibody; and (5) performing hematoxylin counterstaining. The duration of immunohistochemistry is about 3 hours, and shortening the immunohistochemistry time is very necessary for improving the in vitro diagnosis efficiency. Therefore, the invention effectively shortens the duration of immunohistochemical experiments.
Disclosure of Invention
The invention aims to provide a novel immunohistochemical three-in-one reagent formula to solve the technical problem of shortening immunohistochemical experiment time under the condition of not influencing experiment results.
In order to realize the purpose, the specific technical scheme of the novel immunohistochemical three-in-one reagent formula is as follows:
the utilization is transparent; eliminating endogenous peroxidase; the time of the steps such as sealing and the like is almost the same, corresponding reagents are prepared, and the three steps are integrated, so that the time of the immunohistochemical experiment is shortened;
the invention adopts the steps of preparing effective components with transparent immunohistochemistry, endogenous peroxidase elimination, sealing and the like into the same reagent without influencing the immunohistochemical experiment effect, and the specific preparation process is as follows:
transparent Triton X-100 (poly ethanol octyl phenyl ether), hydrogen peroxide for eliminating endogenous peroxidase, blocked goat serum, 0.2g 1% BSA, etc., and other components Tween-20, EDTA, PC300 dissolved in PBS (pH 7.4);
the optimal scheme is as follows: 0.1-0.4g Triton X-100; 1ml-4ml hydrogen peroxide; 0.5ml-2ml goat serum; 0.1g-0.4g BSA (bovine serum albumin); 0.01g to 0.04g of tween-20; 0.001g-0.01g EDTA; 0.1g-0.4g of PC300 and the like were dissolved in 17ml of PBS (pH 7.4).
Further, the feed additive comprises the following raw materials in parts by mass:
0.2g Triton X-100; 2ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
Further, the feed additive comprises the following raw materials in parts by mass:
0.4g Triton X-100; 2ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
Further, the feed additive comprises the following raw materials in parts by mass:
0.1g Triton X-100; 2ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
Further, the feed additive comprises the following raw materials in parts by mass:
0.2g Triton X-100; 4ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
Further, the feed additive comprises the following raw materials in parts by mass:
0.2g Triton X-100; 6ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
Further, the feed additive comprises the following raw materials in parts by mass:
0.2g Triton X-100; 2ml of hydrogen peroxide; 10ml goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
The novel immunohistochemical three-in-one reagent formula disclosed by the invention has the following advantages: the invention effectively shortens the immunohistochemical time and does not influence the immunohistochemical experiment effect.
Detailed Description
In order to better understand the purpose, structure and function of the present invention, the following will describe the formulation of a novel immunohistochemical three-in-one reagent of the present invention in detail with reference to the examples.
Example 1:
mixing 0.2g Triton X-100; 2ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g of PC300 and the like were dissolved in 17ml of PBS (pH 7.4);
example 2:
mixing 0.4g Triton X-100; 2ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g of PC300 and the like were dissolved in 17ml of PBS (pH 7.4).
Example 3:
mixing 0.1g Triton X-100; 2ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g of PC300 and the like were dissolved in 17ml of PBS (pH 7.4).
Example 4:
mixing 0.2g Triton X-100; 4ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g of PC300 and the like were dissolved in 17ml of PBS (pH 7.4).
Example 5:
mixing 0.2g Triton X-100; 6ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g of PC300 and the like were dissolved in 17ml of PBS (pH 7.4).
Example 6:
mixing 0.2g Triton X-100; 2ml of hydrogen peroxide; 10ml goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g of PC300 and the like were dissolved in 17ml of PBS (pH 7.4).
The test method is as follows:
the prepared immunohistochemical three-in-one reagent with components in different proportions is applied to immunohistochemical experiments, and the experimental effects of different formulas and the effect consistency rate when the three steps are respectively acted are observed.
The test results are shown in table 1, and the test results using the conventional experiment are shown in table 2:
table 1.
Sample (I) Consistent rate of immunohistochemical experiment effect
Example 1 100%
Example 2 98%
Example 3 85%
Example 4 90%
Example 5 92%
Example 6 90%
Table 2.
Sample (I) Coloring ratio Experiment time
General experiments 98%±2% 185.5min
As can be seen from tables 1 and 2, the effect of embodiment 1 is the highest in agreement with the step-by-step experiment effect.
It is to be understood that the present invention has been described with reference to certain embodiments, and that various changes in the features and embodiments, or equivalent substitutions may be made therein by those skilled in the art without departing from the spirit and scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular embodiment disclosed, but that the invention will include all embodiments falling within the scope of the appended claims.

Claims (7)

1. The novel immunohistochemical three-in-one reagent formula is characterized by comprising the following raw materials in parts by mass:
0.1-0.4g Triton X-100; 1ml-4ml hydrogen peroxide; 0.5ml-2ml goat serum; 0.1g-0.4g BSA; 0.01g to 0.04g of tween-20; 0.001g-0.01g EDTA; 0.1g-0.4g PC300 was dissolved in 17ml PBS, pH 7.4.
2. The novel immunohistochemical three-in-one reagent formula of claim 1, which is characterized by comprising the following raw materials in mass number:
0.2g Triton X-100; 2ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
3. The novel immunohistochemical three-in-one reagent formula of claim 1, which is characterized by comprising the following raw materials in mass number:
0.4g Triton X-100; 2ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
4. The novel immunohistochemical three-in-one reagent formula of claim 1, which is characterized by comprising the following raw materials in mass number:
0.1g Triton X-100; 2ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
5. The novel immunohistochemical three-in-one reagent formula of claim 1, which is characterized by comprising the following raw materials in mass number:
0.2g Triton X-100; 4ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
6. The novel immunohistochemical three-in-one reagent formula of claim 1, which is characterized by comprising the following raw materials in mass number:
0.2g Triton X-100; 6ml of hydrogen peroxide; 1ml of goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
7. The novel immunohistochemical three-in-one reagent formula of claim 1, which is characterized by comprising the following raw materials in mass number:
0.2g Triton X-100; 2ml of hydrogen peroxide; 10ml goat serum; 0.2g 1% BSA; 0.02g Tween-20; 0.0067g EDTA; 0.2g PC300 in 17ml PBS, pH 7.4.
CN202010769508.3A 2020-08-04 2020-08-04 Novel immunohistochemical three-in-one reagent formula Pending CN111855997A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010769508.3A CN111855997A (en) 2020-08-04 2020-08-04 Novel immunohistochemical three-in-one reagent formula

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010769508.3A CN111855997A (en) 2020-08-04 2020-08-04 Novel immunohistochemical three-in-one reagent formula

Publications (1)

Publication Number Publication Date
CN111855997A true CN111855997A (en) 2020-10-30

Family

ID=72953644

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010769508.3A Pending CN111855997A (en) 2020-08-04 2020-08-04 Novel immunohistochemical three-in-one reagent formula

Country Status (1)

Country Link
CN (1) CN111855997A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN204495841U (en) * 2015-02-10 2015-07-22 桂林医学院附属医院 A kind of SALL4 immunohistochemical staining kit of detection of lung cancer
CN108760450A (en) * 2018-07-18 2018-11-06 杭州依美洛克医学科技有限公司 Secondary antibody coloring system and colouring method for immunohistochemistry autostainer
CN111190001A (en) * 2020-01-10 2020-05-22 苏州睿瀛生物技术有限公司 Special diluent for immunohistochemical antibody and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN204495841U (en) * 2015-02-10 2015-07-22 桂林医学院附属医院 A kind of SALL4 immunohistochemical staining kit of detection of lung cancer
CN108760450A (en) * 2018-07-18 2018-11-06 杭州依美洛克医学科技有限公司 Secondary antibody coloring system and colouring method for immunohistochemistry autostainer
CN111190001A (en) * 2020-01-10 2020-05-22 苏州睿瀛生物技术有限公司 Special diluent for immunohistochemical antibody and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
翁孟武 等: "常用免疫组化染色法", 《免疫皮肤病学基础与临床》 *

Similar Documents

Publication Publication Date Title
EP2698634B1 (en) Biomarker for breast cancer
Osborne et al. Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system
Weiler Antigenic differences between normal hamster kidney and stilboestrol induced kidney carcinoma: histological demonstration by means of fluorescing antibodies
CN109307765A (en) Type pepsinogen II detection kit
CN103116018A (en) Immunohistochemical quality control reference object and quality control method
CN111077302A (en) Glucan signal amplification-based ki67 and p16INK4aDetection kit
CN102405238A (en) Cocktail antibody for determining histological type of carcinoma, determination kit and determination method
CN109307766A (en) Pepsinogen I detection kit
EP2728359B1 (en) A method of sequential and multiple immunostaining for detection of various antigens in the same specimens
CN111781386A (en) Antibody-coated magnetic particle buffer solution, gastrin 17 determination kit and preparation method thereof
CN101846684A (en) Double antibody sandwich enzyme-linked immunosorbent assay kit for detecting AIB1 and preparation method thereof
CN109212193A (en) Kit for clinical detection abnormal prothrombin
CN111855997A (en) Novel immunohistochemical three-in-one reagent formula
JP5039264B2 (en) System for internal qualitative and quantitative verification of marker indices
CN110441537B (en) Method for measuring content of 25-hydroxy vitamin D
CN111363789B (en) Kit and method for simultaneously detecting protein and RNA
CN116381240A (en) Double-dyeing immunohistochemical kit and application
CN110058028A (en) A kind of bis- hydroxy-vitamine D immunity detection reagents of 24,25- and its application
CN106324234B (en) Neu 5 Ac aldolase of modification and its preparation method and application
CN115436542A (en) Method for identifying sheep-derived heparin doping proportion in porcine intestinal mucosa heparin
US20130115630A1 (en) Automated multiplex immunoassay
Tecles et al. Validation of a commercially available human immunoturbidimetric assay for haptoglobin determination in canine serum samples
Tarmann et al. Immunohistochemical detection of an epithelial membrane protein in rat embryos at different stages of development
CN117269472B (en) Universal immunohistochemical auxiliary kit
CN113109325A (en) Pepsinogen I enzymatic chemiluminescence detection kit and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 519040 No. 35, Yong'an Third Road, Hongqi Town, Zhuhai City, Guangdong Province

Applicant after: Zhuhai Lituo Biotechnology Co.,Ltd.

Applicant after: HUNAN LITUO BIOTECHNOLOGY Co.,Ltd.

Address before: 519040 No. 35, Yong'an Third Road, Hongqi Town, Jinwan District, Zhuhai City, Guangdong Province

Applicant before: LITUO BIOTECHNOLOGY CO.,LTD.

Applicant before: HUNAN LITUO BIOTECHNOLOGY Co.,Ltd.

CB02 Change of applicant information
RJ01 Rejection of invention patent application after publication

Application publication date: 20201030

RJ01 Rejection of invention patent application after publication